| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9B | $6.1B | $5.5B | $5.1B | $4.5B | $4.1B | $1.1B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B | $0.9B | $1.0B | $1.0B |
| Operating Income | $1.2B | $1.0B | $0.9B | $1.0B | $0.9B | $0.9B | $0.2B | $0.2B |
| Net Income | $0.2B | $0.2B | $0.2B | $0.6B | $0.5B | $0.3B | $0.0B | $0.2B |
| EPS (Basic) | $0.49 | $0.61 | $0.63 | $1.92 | $1.56 | $1.19 | $0.13 | $0.55 |
| EPS (Diluted) | $0.49 | $0.61 | $0.63 | $1.90 | $1.55 | $1.19 | $0.13 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.1B | $18.7B | $17.5B | $16.1B | $14.5B | $14.1B | $13.8B | $11.9B |
| Current Assets | $1.9B | $1.7B | $1.7B | $1.5B | $1.4B | $1.3B | $1.2B | $1.2B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.1B | $0.3B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.6B | $3.1B | $2.2B | $1.9B | $2.0B | $2.0B | $1.9B | $1.5B |
| Stockholders' Equity | $-1.0B | $-0.5B | $0.2B | $0.6B | $0.9B | $1.1B | $1.5B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.2B | $1.1B | $0.9B | $0.8B | $1.0B | $1.0B | $0.9B |
| Investing Cash Flow | $-2.6B | $-2.1B | $-1.4B | $-1.7B | $-0.5B | $-0.1B | $-0.7B | $-2.2B |
| Capital Expenditures | $2.3B | $1.8B | $1.3B | $0.9B | $0.6B | $0.4B | $0.7B | $0.5B |
| Financing Cash Flow | $1.3B | $0.9B | $0.4B | $0.6B | $-0.2B | $-0.9B | $-0.2B | $0.6B |